DOCSLIB.ORG

Coversheet for Thesis in Sussex Research Online

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Coversheet for Thesis in Sussex Research Online A University of Sussex DPhil thesis Available online via Sussex Research Online: http://eprints.sussex.ac.uk/ This thesis is protected by copyright which belongs to the author. This thesis cannot be reproduced or quoted extensively from without first obtaining permission in writing from the Author The content must not be changed in any way or sold commercially in any format or medium without the formal permission of the Author When referring to this work, full bibliographic details including the author, title, awarding institution and date of the thesis must be given Please visit Sussex Research Online for more information and further details 1 A CONVENIENT SYNTHESIS OF BIOACTIVE CYCLOHEXENEPHOSPHONATES Benoît Carbain October 2005 - January 2009 University of Sussex 1 Contents Acknowledgements ........................................................................................................... 5 Abbreviations .................................................................................................................... 6 Abstract ............................................................................................................................. 9 I. Towards a convenient synthesis of bioactive cyclohexenephosphonates ............... 11 I.1. Theoretical part ..................................................................................................... 11 I.1.1. Previous work ................................................................................................ 11 I.1.2. Barton-Hunsdiecker’s iododecarboxylation and Hirao’s coupling reaction.. 13 I.1.2.1. The halodecarboxylation reaction ........................................................... 13 I.1.2.2. Hirao’s palladium-promoted coupling reaction ...................................... 16 I.1.3. Shikimic acid and the shikimate pathway...................................................... 20 I.1.3.1. Shikimic acid .......................................................................................... 20 I.1.3.2. Shikimate pathway .................................................................................. 21 I.1.3.3. Shikimate dehydrogenase ....................................................................... 22 I.1.3.4. Towards Shikimic acid mimetics ............................................................ 25 I.2. Results and discussion - Synthesis of phospha-isosteres of shikimic acid ........... 27 I.2.1. Retrosynthetic analysis and synthetic strategies towards phospha-shikimic acids and derivatives ............................................................................................... 27 I.2.2. Route A. ......................................................................................................... 28 I.2.2.1. Synthesis of 1-iodo-(3R,4S,5R)-tri-acetoxy-1-cyclohexene 6 from shikimic acid. ...................................................................................................... 28 I.2.2.2. Introduction of the phosphonate group: Synthesis of Dimethyl (3R,4S,5R)-tri-acetoxy-1-cyclohexene-1-phosphonate 9 and deprotection........ 32 I.2.3. A alternate protecting group strategy towards shikimic acid derivatives. ..... 34 I.2.3.1. A new protecting group strategy. ............................................................ 34 2 I.2.3.2. Iododecarboxylation and phosphonate introduction: key steps towards 3- dehydro-‘phospha’-shikimic acid derivatives. .................................................... 36 I.2.4. Route B. ......................................................................................................... 38 I.2.5. Dehydroquinase assay.................................................................................... 40 I.3. Conclusion. ........................................................................................................... 41 II. Efficient synthesis of novel, highly active phospha-isosteres of the Influenza neuraminidase inhibitor Oseltamivir. .............................................................................. 41 II.1. Theoretical part. ................................................................................................... 41 II.1.1. Influenza. ...................................................................................................... 41 II.1.1.1. Introduction to influenza viruses ........................................................... 41 II.1.1.2. Influenza A virus H5N1 ........................................................................ 42 II.1.1.3. The role of neuraminidase and hemagglutinin in influenza virus replication ............................................................................................................ 44 II.1.1.4. The influenza virus haemagglutinin membrane glycoprotein ............... 46 II.1.1.5. The influenza virus neuraminidase membrane glycoprotein................. 49 II.1.2. Oseltamivir. .................................................................................................. 51 II.1.2.1. A neuraminidase inhibitor. .................................................................... 51 II.1.2.2. Oseltamivir syntheses. ........................................................................... 53 II.1.3. ‘Phospha’-Tamiflu syntheses. ...................................................................... 56 II.2. Results and discussion. ........................................................................................ 58 II.2.1. Strategy towards ‘phospha’-Tamiflu and its derivatives. ............................. 58 II.2.2. Key steps towards the key intermediate 34. ................................................. 58 II.2.2.1. A first approach. .................................................................................... 58 II.2.2.2. Protected amino derivatives of Tamiflu’s precursor. ............................ 60 II.2.2.3. Optimised route leading to key monoalkyl phosphonate intermediate 34. ............................................................................................................................. 63 II.2.3. Synthesis of ‘phospha’-Tamiflu derivatives ................................................. 66 II.2.3.1. Synthesis of ‘phospha’-Tamiflu 35 and its methyl ester 36 .................. 66 3 II.2.3.2. Introduction of an hydrophobic moiety by alkylation: synthesis of the hexyl ester 40 of ‘phospha’-Tamiflu ................................................................... 67 II.2.3.3. Introduction of a sugar moiety by alkylation: Synthesis of α(2-6)- sialoglycoconjugate mimetic 46 .......................................................................... 69 II.2.4. An alternative approach to mixed diesters of ‘phospha’-Tamiflu ................ 71 II.2.4.1. Introduction of a sugar moiety by phosphonate coupling: Synthesis of α(2,3)-sialoglycoconjugate mimetic 54............................................................... 71 II.2.4.2. Introduction of a variable ω-thioacetyl linker for immobilisation and oligomerisation of the ‘phospha’-Tamiflu motif ................................................ 75 II.2.5. Inhibition of neuraminidase activity ............................................................. 77 II.2.6. Future scope.................................................................................................. 78 II.3. Conclusion ........................................................................................................... 79 III. Experimental section ........................................................................................... 80 III.1. General procedures............................................................................................. 80 III.2. Synthetic procedures and compound characterization ....................................... 81 III.2.1. ‘Phospha’-shikimic derivatives ................................................................... 81 III.2.2. ‘Phospha’-Tamiflu derivatives .................................................................... 97 III.2.3. Inhibition of neuraminidase activity of influenza viruses from allantoic fluid from infected eggs ........................................................................................ 124 IV. References ......................................................................................................... 126 V. List of publications and posters............................................................................. 133 Appendix 1 : Crystal structures ..................................................................................... 134 ORTEP-generated structure of (3R,4S,5R)-tri-acetoxy-1 cyclohexene-1-phosphonate 9 ................................................................................................................................. 134 ORTEP-generated structure of (3R,4S,5R)-3-[(tert-butyldimethylsilyl)oxy]-4,5-(2,3- dimethoxy-butan-2,3-dioxy)-cyclohex-1-ene-1-carboxylic acid 13 ......................... 138 ORTEP-generated structure of Dimethyl (3R,4S,5R)- 3-hydroxy-4,5-(2,3-dimethoxy- butan-2,3-dioxy)-cyclohex-1-ene-1-phosphonate 16 ................................................ 146 4 ORTEP-generated structure of (3R,4R,5S)-4-acetylamino-5-azido-3-(1- ethylpropoxy)-1-iodocyclohexene 25 ....................................................................... 151 ORTEP-generated structure of (3R,4R,5S)-4-acetylamino-5-N-tert-Butoxycarbonyl- amino-3-(1-ethylpropoxy)-1-iodocyclohexene 32 .................................................... 157 Appendix 2 : 1H NMR Spectra.....................................................................................
Load more

Recommended publications
  • An Integrated Flow and Batch-Based Approach for the Synthesis of O-Methyl Siphonazole Amarcus Combined Flow and Batch Synthesis of O-Methyl Siphonazole Baumann, Ian R
    LETTER 1375 An Integrated Flow and Batch-Based Approach for the Synthesis of O-Methyl Siphonazole AMarcus Combined Flow and Batch Synthesis of O-Methyl Siphonazole Baumann, Ian R. Baxendale, Malte Brasholz, John J. Hayward, Steven V. Ley, Nikzad Nikbin Innovative Technology Centre, Department of Chemistry, University of Cambridge, Lensfield Road, Cambridge CB2 1EW, UK E-mail: [email protected] Received 21 February 2011 has transformed flow chemistry from an academic interest Abstract: The bisoxazole containing natural product O-methyl si- phonazole was assembled using a suite of microreactors via a flow- to a valuable enabling technology that overcomes several based approach in concert with traditional batch methods. The use of the bottlenecks traditionally faced by synthetic chem- 6 of a toolbox of solid-supported scavengers and reagents to aid puri- ists. As such the generation and immediate use of hazard- fication afforded the natural product in a total of nine steps. ous, toxic, or unstable intermediates7 has been reported as Key words: oxazoles, Claisen condensation, flow chemistry, well as the possibility to more reliably perform reaction microreactors, solid-supported reagents scale-up.8 Furthermore, flow reactors can be transformed into automated platforms by the addition of liquid han- dling and fraction collector modules expanding the work- As part of our ongoing interest in oxazole-containing nat- ing capabilities of the units and allowing for 24/7 working 9 ural products,1 we have devised a synthetic route to the regimes. Finally, individual reactions can be telescoped bisoxazole alkaloid O-methyl siphonazole (2), which was into one continuous flow sequence, thus avoiding the iter- discovered by König and co-workers in 2006, along with ative isolation, purification, and reprocessing of interme- 10 the C-21-demethylated parent compound siphonazole (1, diates.
    [Show full text]
  • The Degradation of Carboxylic Acid Salts by Means of Halogen the Hunsdieceerreaction Robert G
    THE DEGRADATION OF CARBOXYLIC ACID SALTS BY MEANS OF HALOGEN THE HUNSDIECEERREACTION ROBERT G. JOHNSON Department of Chemistry, Xavier University, Cincinnati 7, Ohio AND ROBERT K. INGHAM Department of Chemistry, Ohio University, Athens, Ohio Received November 17, 1966 CONTENTS I. Introduction.. ...... 11. Synthetic applicatio A. Aliphatic halides B. Alicyclic halides. C. Aromatic halides D. Heterocyclic hali 111. Materials and methods ....................................... 248 IV. Mechanisms., ...... V. Related reactions. ....... ......................................... 259 VI. Summary.. ......... VII. References.. ................................................................. 263 VIII. Addendum. ........................... .. 268 I. INTRODUCTION The degradation of a carboxylic acid salt in anhydrous medium by means of halogen to a halide of one less carbon atom than the original acid can be ex- pressed by the equation: RCOOM + Xz -+ RX + COz + MX Largely because of the extensive contributions of the Hunsdieckers (96, 97, 98, 99, 100, 101, 102) to our knowledge of this reaction, many chemists refer to the reaction under discussion as the “Hunsdiecker reaction.” Others designate the reaction by the names “silver salt reaction” or “silver salt-halogen reac- tion.” It has been proposed (95) that the name “Borodine reaction” be used, in recognition of the discovery of the reaction by Borodine (33). The authors of a recent book (179) incorrectly name this reaction M the Simonini reaction. The reviewers favor the use of “Hunsdiecker reaction,” if a name is to be given to this reaction, because of the many instances of the use of this termi- nology already in the literature and because of the large amount of developmental work carried out by the Hunsdieckers. The often-used descriptive names are contraindicated by the fact that the reaction is successful with salts other than silver salts, halogens other than bromine can be used, and the reaction of salts 219 220 ROBERT G.
    [Show full text]
  • (12) Patent Application Publication (10) Pub. No.: US 2005/0065361A1 Deshmukh Et Al
    US 2005OO65361A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2005/0065361A1 Deshmukh et al. (43) Pub. Date: Mar. 24, 2005 (54) PROCESS FOR PREPARING ALKYLARYL (22) Filed: Sep. 22, 2003 CHLOROFORMATES Publication Classification (76) Inventors: Abdul Rakeeb Abdul Subhan Deshmukh, Maharashtra (IN); Vikas (51) Int. Cl." ........................... C07C 69/74; C07C 69/96 Kalyanrao Gumaste, Maharashtra (IN) (52) U.S. Cl. .............................................................. 558/280 Correspondence Address: (57) ABSTRACT NIXON & VANDERHYE, PC The present invention discloses an improved method for the 1100 N GLEBE ROAD preparation of alky/aryl chloroformates directly from alco 8TH FLOOR hols and triphosgene. This method is simple, mild and ARLINGTON, VA 22201-4714 (US) efficient avoids use of hazardous phosgene. It can be used for the preparation of various aryl as well as alkyl chlorofor (21) Appl. No.: 10/665,410 mates in excellent yields. US 2005/0065361 A1 Mar. 24, 2005 PROCESS FOR PREPARING ALKYLARYL Maligres, K. C. Nicolau, W. Wrasidio Bioorg. Med. Chem. CHLOROFORMATES Lett. 1993, 3, 1051. (c) D. C. Horwell, J. Hughes, J. Hunter, M. C. Pritchard, R. S. Richardson, E. Roberts, G. N. FIELD OF THE INVENTION Woodruff J. Med. Chem., 1991, 34, 404 and tertiary amines as base H. Eckert, B. Forster, Angew. Chem. Int. Ed. Engl., 0001. The present invention relates to a process for 1987,26,894). Hydroquinone is also used in the preparation preparing alkyl/aryl chloroformates. More particularly, the of chloroformates from triphosgene G. Van den Mooter, C. present invention relates to a process for preparing com Samyn, R. Kinget Int. J. Pharm., 1993, 97, 133).
    [Show full text]
  • 5 Phosphorus Oxychloride1 Acute Exposure Guideline Levels
    Acute Exposure Guideline Levels for Selected Airborne Chemicals: Volume 10 Committee on Acute Exposure Guideline Levels Committee on Toxicology Board on Environmental Studies and Toxicology Division on Earth and Life Studies Copyright © National Academy of Sciences. All rights reserved. Acute Exposure Guideline Levels for Selected Airborne Chemicals: Volume 10 THE NATIONAL ACADEMIES PRESS 500 FIFTH STREET, NW WASHINGTON, DC 20001 NOTICE: The project that is the subject of this report was approved by the Governing Board of the National Research Council, whose members are drawn from the councils of the National Academy of Sciences, the National Academy of Engineering, and the Insti- tute of Medicine. The members of the committee responsible for the report were chosen for their special competences and with regard for appropriate balance. This project was supported by Contract No. W81K04-06-D-0023 and EP-W-09-007 be- tween the National Academy of Sciences and the U.S. Department of Defense and the U.S. Environmental Protection Agency. Any opinions, findings, conclusions, or recom- mendations expressed in this publication are those of the author(s) and do not necessarily reflect the view of the organizations or agencies that provided support for this project. International Standard Book Number-13: 978-0-309-21987-7 International Standard Book Number-10: 0-309-21987-6 Additional copies of this report are available from The National Academies Press 500 Fifth Street, NW Box 285 Washington, DC 20055 800-624-6242 202-334-3313 (in the Washington metropolitan area) http://www.nap.edu Copyright 2011 by the National Academy of Sciences.
    [Show full text]
  • Synthesis of Mollugin and (3S,4R)-Trans-3,4-Dihydroxy-3,4-Dihydromollugin
    Accepted Manuscript Asymmetric epoxidation of chromenes mediated by iminium salts: Synthesis of mollugin and (3S,4R)-trans-3,4-dihydroxy-3,4-dihydromollugin Philip C. Bulman Page, Yohan Chan, Abu Hassan Noor Armylisas, Mohammed Alahmdi PII: S0040-4020(16)31129-2 DOI: 10.1016/j.tet.2016.10.070 Reference: TET 28211 To appear in: Tetrahedron Received Date: 30 July 2016 Revised Date: 22 October 2016 Accepted Date: 31 October 2016 Please cite this article as: Page PCB, Chan Y, Noor Armylisas AH, Alahmdi M, Asymmetric epoxidation of chromenes mediated by iminium salts: Synthesis of mollugin and (3S,4R)-trans-3,4-dihydroxy-3,4- dihydromollugin, Tetrahedron (2016), doi: 10.1016/j.tet.2016.10.070. This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. provided by University of East Anglia digital repository View metadata, citation and similar papers at core.ac.uk CORE brought to you by ACCEPTED MANUSCRIPT Graphical Abstract MANUSCRIPT ACCEPTED Asymmetric Epoxidation of Chromenes Mediated by Iminium Salts: Synthesis of Mollugin and (3 S,4 R)- ACCEPTED MANUSCRIPT trans -3,4-Dihydroxy-3,4-Dihydromollugin Philip C. Bulman Page, a* Yohan Chan, a Abu Hassan Noor Armylisas, b Mohammed Alahmdi c a School of Chemistry, University of East Anglia, Norwich Research Park, Norwich, Norfolk NR4 7TJ, U.K.
    [Show full text]
  • 100011-1 Cesium (1000Μg/Ml in 1% HNO3)
    100011-1 Cesium (1000μg/mL in 1% HNO3) High-Purity Standards Chemwatch Hazard Alert Code: 3 Catalogue number: 1000-11-1 Issue Date: 03/07/2017 Version No: 3.3 Print Date: 03/07/2017 Safety Data Sheet according to OSHA HazCom Standard (2012) requirements S.GHS.USA.EN SECTION 1 IDENTIFICATION Product Identifier Product name 100011-1 Cesium (1000μg/mL in 1% HNO3) Synonyms 1000μg/mL Cesium in 1% HNO3 Proper shipping name Corrosive liquid, acidic, inorganic, n.o.s. (contains nitric acid) Other means of 1000-11-1 identification Recommended use of the chemical and restrictions on use Relevant identified uses Use according to manufacturer's directions. Name, address, and telephone number of the chemical manufacturer, importer, or other responsible party Registered company name High-Purity Standards Address PO Box 41727 SC 29423 United States Telephone 843-767-7900 Fax 843-767-7906 Website highpuritystandards.com Email Not Available Emergency phone number Association / Organisation INFOTRAC Emergency telephone 1-800-535-5053 numbers Other emergency telephone 1-352-323-3500 numbers SECTION 2 HAZARD(S) IDENTIFICATION Classification of the substance or mixture Classification Metal Corrosion Category 1, Skin Corrosion/Irritation Category 1A, Serious Eye Damage Category 1 Label elements GHS label elements SIGNAL WORD DANGER Hazard statement(s) H290 May be corrosive to metals. H314 Causes severe skin burns and eye damage. Hazard(s) not otherwise specified Not Applicable Precautionary statement(s) Prevention Continued... Chemwatch: 9-245281 Page 2 of 10 Issue Date: 03/07/2017 Catalogue number: 1000-11-1 100011-1 Cesium (1000μg/mL in 1% HNO3) Print Date: 03/07/2017 Version No: 3.3 P260 Do not breathe dust/fume/gas/mist/vapours/spray.
    [Show full text]
  • Organic Seminar Abstracts
    L I B RA FLY OF THE U N IVERSITY OF 1LLI NOIS Q.54-1 Ii£s 1964/65 ,t.l P Return this book on or before the Latest Date stamped below. Theft, mutilation, and underlining of books are reasons for disciplinary action and may result in dismissal from the University. University of Illinois Library OCfcfcsrm L161— O-1096 Digitized by the Internet Archive in 2012 with funding from University of Illinois Urbana-Champaign http://archive.org/details/organicsemi1964651univ s ORGANIC SEMINAR ABSTRACTS 196^-65 Semester I Department of Chemistry and Chemical Engineering University of Illinois ' / SEMINAR TOPICS I Semester I96U-I965 f"/ ( Orientation in Sodium and Potassium Metalations of Aromatic Compounds Earl G. Alley 1 Structure of Cyclopropane Virgil Weiss 9 Vinylidenes and Vinylidenecarbenes Joseph C. Catlin 17 Diazene Intermediates James A. Bonham 25 Perfluoroalkyl and Polyfluoroalkyl Carbanions J. David Angerer 3^ Free Radical Additions to Allenes Raymond Feldt 43 The Structure and Biosynthesis of Quassin Richard A. Larson 52 The Decomposition of Perester Compounds Thomas Sharpe 61 The Reaction of Di-t -Butyl Peroxide with Simple Alkyl, Benzyl and Cyclic Ethers R. L. Keener 70 Rearrangements and Solvolysis in Some Allylic Systems Jack Timberlake 79 Longifolene QQ Michael A. Lintner 00 Hydrogenation ! Homogeneous Catalytic Robert Y. Ning 9° c c Total Synthesis of ( -) -Emetime R. Lambert 1* Paracyclophanes Ping C. Huang 112 Mechanism of the Thermal Rearrangement of Cyclopropane George Su 121 Some Recent Studies of the Photochemistry of Cross -Conjugated Cyclohexadienones Elizabeth McLeister 130 The Hammett Acidity Function R. P. Quirk 139 Homoaromaticity Roger A.
    [Show full text]
  • Chapter 6 Industrial Applications of Multicomponent Reactions (Mcrs)
    University of Groningen Innovative multicomponent reactions and their use in medicinal chemistry Zarganes Tzitzikas, Tryfon IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it. Please check the document version below. Document Version Publisher's PDF, also known as Version of record Publication date: 2017 Link to publication in University of Groningen/UMCG research database Citation for published version (APA): Zarganes Tzitzikas, T. (2017). Innovative multicomponent reactions and their use in medicinal chemistry. University of Groningen. Copyright Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons). Take-down policy If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim. Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the number of authors shown on this cover page is limited to 10 maximum. Download date: 24-09-2021 CHAPTER 6 INDUSTRIAL APPLICATIONS OF MULTICOMPONENT REACTIONS (MCRS) Chapter contained in the Rodriguez-Bonne book Stereoselectve Multple Bond-Forming Transformatons in Organic Synthesis 2015 by John Wiley & Sons, Inc. Tryfon Zarganes – Tzitzikas, Ahmad Yazbak, Alexander Dömling Chapter 6 INTRODUCTION Multcomponent reactons (MCRs) can be defned as processes in which three or more reactants introduced simultaneously are combined through covalent bonds to form a single product, regardless of the mechanisms and protocols involved.[1] Many basic MCRs are name reactons, for example, Ugi,[2] Passerini,[3] van Leusen,[4] Strecker,[5] Hantzsch,[6] Biginelli,[7] or one of their many variatons.
    [Show full text]
  • Swager for the Degree of California Institute
    PRECURSOR ROUTES TO CONDUCTING POLYMERS FROM THE RING-OPENING METATHESIS POLYMERIZATION OF CYCLIC OLEFINS Thesis by Timothy Manning Swager In Partial Fulfillment of the Requirements For the Degree of Doctor of Philosophy California Institute of Technology Pasadena, California 1988 (Submitted May 16, 1988) I a ELECTRONS TALK TO ME! Oh elusive electron how can I set thee free? I’ll unlock your chains just show me the key. Should I destroy your captors those localized bonds? Or would you like something else should I search beyond? I want to let you run and move about with ease. And you may travel in pairs or alone if you please. Lead me the way to that magic superconductive state. And I will do my best to try to accommodate. I’ll build you a band of whatever width you desire. And with my friend polymer chemistry I’ll fashion you a wire. You hold the secrets that can make the world a better place. And I have become curious and decided to join the chase. Oh magnificent electrons hear my plea I have come to set you free. Timothy M. Swager 1988 11 ACKNOWLEDGMENTS First and foremost, I want to thank my wife and best friend Anne for her undaunting support and companionship. I cannot imagine life without her and her influence has made me a happier and stronger person. To my research advisor Bob Grubbs, I owe considerable gratitude and thanks. His guidance will have lasting influence over my career as a chemist. Bob has allowed me to chase many pipe dreams in his laboratory, yet given me the necessary guidance to keep my research on course.
    [Show full text]
  • US2278550.Pdf
    April 7, 1942. D. J. OER E. A. 2,278,550 PREPARATION OF ALKALI METAL ALKOXIDES Filed June 21, 1939 REACTION ------ REGENERATION OFMX FROM M-represents an alkali metal N-represents a number from 2 to 3 R-represents an alkyl group X-represents the anion of a weak acid Donald D. Lee Donald J. Loder NVENTOR BY 232 az - ATTORNEY Patented Apr. 7, 1942 2,278,550 UNITED STATES PATENT OFFICE 2,278,550 PREPARATION OF ALKALI METAL ALKOXDES Donald J. Loder and Donald D. Lee, Wilmington, Del, assignors to E. I. du Pont de Nemours & Company, Wilmington, Del., a corporation of Delaware Application June 21, 1939, Serial No. 280,308 16 Claims. (CI. 260-632) The invention relates to improvements in the and R is an alkyl, or aralkyl radical which may be manufacture of metal alkoxides and more particu Saturated, unsaturated, substituted or unsub larly to the preparation of alkali metal alkoxides stituted. by the interaction of alcohols with alkali metal In Reactions 1 and 2, an alkali metal salt of a salts of weak acids. weak acid is digested with an alcohol at an ap Alkali metal alkoxides have been prepared by propriate temperature, the digestion being Con. direct reaction of the alkali metal as such with tinued until equilibrium has been substantially an alcohol. or by action of an alkali metal hy reached. The equilibrium mixture is filtered for. droxide. upon an alcohol. The higher cost of the the separation of any undissolved (MX or M3X) first of these methods has limited somewhat the O salt and the resulting solution (or filtrate) is industrial use of the alkoxide thus prepared and found to contain an alkali metal alkoxide, or much effort has been expended in endeavors to aralkoxide, (MOR) hereinafter called 'al make the second more commercially practicable.
    [Show full text]
  • NEW at ROTH June 2014 NEW Products and Programme Extensions in Chemicals
    NEW at ROTH June 2014 NEW Products and Programme Extensions in Chemicals Content NEW Products Chemicals .................................... 2-14 NEW at ROTH | NEW at ROTH | NEW at ROTH | NEW at ROTH | NEW at ROTH | NEW at ROTH | NEW at ROTH | NEW at ROTH | NEW at ROTH | NEW at RO NEW Chemicals June 2014 Acids Nitric acid 40 % Biochemicals ® Nitric acid 40 % Cellpure Nitr Hydrochloric acid 37 % 40 %, pure HNO3 M 63,0 g/mol L-Alanyl-L-glutamine Hydrochloric acid 37 % D 1,25 Hydr 37 %, techn. [7697-37-2] O O Hydrogen chloride EC No 231-714-2 · UN No. 2031 HCl ADR 8 II · WGK 1 H2N OH M 36,46 g/mol h Danger H290-H314 HN O D ~1,19 Type analysis: [7647-01-0] Assay. ...................................................... 39,0-41,0 % H2N CH3 EC No 231-595-7 · UN No. 1789 Chloride (Cl). ................................................ b0,001 % ADR 8 II · WGK 1 Iron (Fe)...................................................... 0,0005 % L-Alanyl-L-glutamine Alan Danger H290-H314-H335 Heavy metals (as Pb). ................................ 0,0001 % 99 %, CELLPURE® h g Ash............................................................... b0,001 % Type analysis: C8H15N3O4 Assay..............................................................36,5 % 6748.1 1 l glass 17,10 € M 217,22 g/mol Density (20 °C). ........................................1,183-1,187 Original pack 6 x 1 l 16,25/1 l mp 209 °C (dec.) Lead (Pb)....................................................0,0001 % 6748.2 5 l plastic 42,90 € Solubility: 450 g/l (H2O, 20 °C) 7476.1 1 l glass 13,85 € Original pack 2 x 5 l 40,76/5 l [39537-23-0] 6748.3 10 l plastic 53,65 € WGK 1 Original pack 6 x 1 l 13,16/1 l 7476.2 2,5 l glass 19,25 € 6748.4 25 l plastic 103,20 € Type analysis: Original pack 4 x 2,5 l 18,29/2,5 l Appearance.
    [Show full text]
  • Enzyme and Lateral Flow Monoclonal Antibody-Based Immunoassays To
    www.nature.com/scientificreports OPEN Enzyme and lateral fow monoclonal antibody‑based immunoassays to simultaneously determine spirotetramat and spirotetramat‑enol in foodstufs Ramón E. Cevallos‑Cedeño1,3, Consuelo Agulló2, Antonio Abad‑Fuentes1, Antonio Abad‑Somovilla2 & Josep V. Mercader1* Spirotetramat is employed worldwide to fght insect pests due to its high efciency. This chemical is quickly metabolized by plants into spirotetramat‑enol, so current regulations establish that both compounds must be determined in foodstufs for monitoring purposes. Nowadays, immunochemical methods constitute rapid and cost‑efective strategies for chemical contaminant analysis at trace levels. However, high‑afnity binders and suitable bioconjugates are required. In this study, haptens with opposite functionalisation sites were synthesized in order to generate high‑afnity monoclonal antibodies. A direct competitive enzyme‑linked immunosorbent assay with an IC50 value for the sum of spirotetramat and spirotetramat‑enol of 0.1 μg/L was developed using selected antibodies and a novel heterologous bioconjugate carrying a rationally‑designed hapten. Studies with fortifed grape, grape juice, and wine samples showed good precision and accuracy values, with limits of quantifcation well below the maximum residue limits. Excellent correlation of results was observed with a standard reference chromatographic method. As a step forward, a lateral fow immunoassay was developed for onsite screening analysis of spirotetramat in wine. This assay was successfully validated according to Regulation 519/2014/EU for semi‑quantitative methods at concentrations in line with the legal levels of spirotetramat and spirotetramat‑enol in grapes, with a satisfactory false suspect rate below 2%. Spirotetramat (SP), also known as BYI08330, was developed by Bayer CropScience a few years ago, and it was approved as a pesticide in the European Union and in the USA in 20141,2.
    [Show full text]